Human Apolipoprotein A-I (Apo A1) ELISA Kit

$407.00

Catalog Number: EA5301-1

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Sandwich ELISA

Entrez Gene

335

Components

Biotinylated Human Apolipoprotein A-I Antibody, Chromogen Substrate (1x), Human Apolipoprotein, Human Apolipoprotein A-I Microplate, MIX Diluent Concentrate (10x), Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

0.95 ng/ml

Range

3.125 – 200 ng/ml

Samples Type

CSF, Milk, Plasma, Saliva, Serum, Urine

Associated Disease

Cancer, Cardiovascular, Heart Disease, Metabolism

Species

Human

UniProt

P02647

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (87 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

Role of DJ-1 and Apo A1 as biomarkers in Parkinson's disease: an observational case-control study

Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and …

Phytosterols and omega 3 supplementation exert novel regulatory effects on metabolic and inflammatory pathways: a proteomic study

  • https://www.mdpi.com/2072-6643/9/6/599
  • C Lambert, J Cubedo, T Padró, J Sánchez-Hernández… - Nutrients, 2017 - mdpi.com
  • Cardiovascular disease (CVD) remains one of the major causes of death and disability worldwide. In addition to drug treatment, nutritional interventions or supplementations are …

Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome

  • https://www.tandfonline.com/doi/abs/10.1179/1351000214Y.0000000103
  • JK Taylor, EP Plaisance, AJ Mahurin, ML Mestek… - Redox …, 2015 - Taylor & Francis
  • Our purpose was to characterize changes in paraoxonase 1 (PON1) activity and concentration after single aerobic exercise sessions conducted before and after 6 weeks of niacin …

High performance lipoprotein profiling for cardiovascular risk assessment

Intervenciones nutricionales en la prevención cardiovascular y efectos de los factores de riesgo en el tejido adiposo

  • https://diposit.ub.edu/dspace/handle/2445/148837
  • C Lambert Goitia - 2019 - diposit.ub.edu
  • [spa] Las enfermedades cardiovasculares son una de las principales causas de mortalidad y morbilidad a nivel mundial, apareciendo como consecuencia de la acumulación de …

Diseño de una herramienta auxiliar en el diagnóstico de cáncer de pulmón mediante la cuantificación de proteínas biomarcadoras utilizando redes neuronales …

Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels

Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke

Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study

Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function

Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue

Leptin and Tumor necrosis factor alpha in breast

Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection

Diagnostic value of apolipoprotein A1 in neonatal sepsis

Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus

Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study

Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection

Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria

Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM

Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.

Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients

Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study

ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma

The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols

Paraoxonase Responses to Exercise and Niacin Therapy in Men with Metabolic Syndrome

Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics

Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity

A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients

Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers

Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children

Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction

Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics

The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease

Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients

The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents

Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach

Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD

High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis

Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level

Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema

Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications

High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease

* Grover A et al. (2020) Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels. Cureus.12(1):e6542.

* Eldeeb MA et al. (2020) Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke. Egyp. J.Neurology Psychia. Neurosurgery. 56:3.

* Cieluch A et al. (2020) Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study. Arch. Med. Sci. 18:1-8.

* Tortorici MA et al. (2019) Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function. Clinical Pharmacology in Drug Development. 8(5):628-636

* Lambert Goitia C (2019) Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue. University of Barcelona. Ph.D. Thesis.

* Hussein A et al. (2019) Leptin and Tumor necrosis factor alpha in breast. SOHAG MED. J. 23(1):235-247.

* Ahmed NS et al. (2019) Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection. Sohag Med. J. 23(2):2 Apr 2019.

* El-Gendy FM et al. (2018) Diagnostic value of apolipoprotein A1 in neonatal sepsis. Menoufia Medical Journal. 31(3):1011-1017

* Ebara S et al. (2018) Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus. J.Thrombo. Thrombolysis. 45(2):200?205.

* Shree R et al. (2019) Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study. Annals of Movement Disorders. 2(3):109-114.

* Ray S et al. (2017) Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection. Sci Rep. 7(1):4400.

* Ray S et al. (2017) Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Sci Rep. 6:24557.

* Omar NN et al. (2017) Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM. Bulletin of Faculty of Pharmacy, Cairo University. 55(2): 325-331.

* Limareva LV et al. (2017) Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.

* Grover A et al. (2017) Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients. Indian Heart J. 69(1):6-10.

* Lambert C et al. (2017) Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study. Nutrients. 9(6):599.

* Lin C et al. (2016) ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma. Medicine (Baltimore). 95(31):e4527.

* Wu T et al. (2015) The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. J Pharmacol Sci. 127(3):251-9. doi: 10.1016/j.jphs.2014.12.002. Epub 2014 Dec 15

* Taylor JK (2015) Paraoxonase Responses to Exercise and Niacin Therapy in Men with Metabolic Syndrome. Redox Rep. 20(1):42-8.

* Sharma S (2015) Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics. 15(2-3):394-407

* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113

* Cubedo J et al. (2015) A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients. J Lipid Res. 56(9):1762-73.

* Sharma S et al. (2014) Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers. Sci Rep. 4:7140. doi: 10.1038/srep07140

* Martos-Moreno GA et al. (2014) Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children. Int J Pediatr Endocrinol. 2014(1):9. doi: 10.1186

* Cubedo J et al. (2014) Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction. Transl Res.164(3):209-22.

* Wen Q et al. (2013) Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics. Biochem Biophys Res Commun. 438(3):473-8.

* Wang DX et al. (2013) The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease. Chin Med J 126 (19): 3656-3661

* Miyamoto-Sasaki M et al. (2013) Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb. 20(9):708-16.

* Ghorbanian B et al. (2013) The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents. Int J Endocrinol Metab. 2013 Spring;11(2):76-81

* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1

* Choi GS et al. (2013) Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD. Clin Exp Allergy. 43(7):730-40.

* Larner CD (2012) High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment. Texas A&M University.

* Kootte RS et al. (2015) Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]. J Lipid Res. 56(3):703-712.

* Charles-Schoeman C et al. (2012) Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 71(7):1157-1162

* Vacirca D et al. (2011) Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level. J Alzheimers Dis. 26(3):441-445.

* Ahmad Y et al. (2011) Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema.Funct Integr Genomics. 11(3):407-17.

* Ling XB et al. (2010) Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics. 2010 Dec;10(24):4415-30

* Chen GL et al. (2010) High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease. Chin Med J (Engl). 123(6):658-663.

Loading data...